Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient Sir, Familial Mediterranean fever (FMF) is an inherited auto-inflammatory disease characterized by frequently relapsing fever and polyserositis. 1 Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune inflammatory disease that is characterized by antibody production against cell nucleus elements. 2 A 13-year-old girl was admitted to our pediatric rheumatology clinic with complaints of recurrent arthralgia and abdominal pain. On physical examination, she had malar rash. She had appendectomy on medical history. Her parents were consanguineous. Investigations demonstrated a raised erythrocyte sedimentation rate (ESR) (75 mm/h) and C-reactive protein (CRP) (4.8 mg/dl, normal range: 0-0.8). There was anaemia (Hb 9.5 g/dl) but normal WBC (6300/mm 3 ) and platelet count (233,000/mm 3 ). Anti-nuclear antibody (ANA) and anti-double stranded DNA (anti-dsDNA) were both positive. She was hypocomplementemic with 65 mg/dl C3 (normal range: 83-177) and 5.8 mg/dl C4 (normal range: 12-36). On urine analysis, she had microscopic haematuria. A 24-hour urinary protein collection revealed 0.25 gr/24 h. Cardiovascular, respiratory system and abdominal examination were normal. Anticardiolipin Ig G and M, anti-histone, anti-Ro-La antibodies were negative. Kidney biopsy was performed and revealed mesangial proliferative lupus nephritis (class III). A diagnosis of SLE was made according to the American College of Rheumatology (ACR) 1997 revised criteria. Prednisolone and hydroxychloroquine treatment were started. She was also started on pulse cyclophosphamide therapy because of renal involvement. Although she received her therapy regularly, abdominal pain attacks and arthralgia continued. Her ESR and CRP values were persistently high. Subsequent testing showed that she was homozygous for V726A of MEFV, the gene responsible for FMF. She was started on colchicine (1 mg/day). Thereafter she had no more complaints.
Sir,
Familial Mediterranean fever (FMF) is an inherited auto-inflammatory disease characterized by frequently relapsing fever and polyserositis. 1 Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune inflammatory disease that is characterized by antibody production against cell nucleus elements. 2 A 13-year-old girl was admitted to our pediatric rheumatology clinic with complaints of recurrent arthralgia and abdominal pain. On physical examination, she had malar rash. She had appendectomy on medical history. Her parents were consanguineous. Investigations demonstrated a raised erythrocyte sedimentation rate (ESR) (75 mm/h) and C-reactive protein (CRP) (4.8 mg/dl, normal range: 0-0.8). There was anaemia (Hb 9.5 g/dl) but normal WBC (6300/mm 3 ) and platelet count (233,000/mm 3 ). Anti-nuclear antibody (ANA) and anti-double stranded DNA (anti-dsDNA) were both positive. She was hypocomplementemic with 65 mg/dl C3 (normal range: 83-177) and 5.8 mg/dl C4 (normal range: 12-36). On urine analysis, she had microscopic haematuria. A 24-hour urinary protein collection revealed 0.25 gr/24 h. Cardiovascular, respiratory system and abdominal examination were normal. Anticardiolipin Ig G and M, anti-histone, anti-Ro-La antibodies were negative. Kidney biopsy was performed and revealed mesangial proliferative lupus nephritis (class III). A diagnosis of SLE was made according to the American College of Rheumatology (ACR) 1997 revised criteria. Prednisolone and hydroxychloroquine treatment were started. She was also started on pulse cyclophosphamide therapy because of renal involvement. Although she received her therapy regularly, abdominal pain attacks and arthralgia continued. Her ESR and CRP values were persistently high. Subsequent testing showed that she was homozygous for V726A of MEFV, the gene responsible for FMF. She was started on colchicine (1 mg/day). Thereafter she had no more complaints.
We had not considered FMF in the presenting patient, as abdominal pain and arthralgia could also be a feature of SLE. Moreover, SLE and FMF are very rarely seen together. In FMF patients have increased prevalence of rheumatic diseases, and Behc¸et's disease, Crohn's disease, Henoch-Schonlein purpura, juvenile idiopathic arthritis and polyarteritis nodosa have been reported previously. 3 However only a few cases of coexistence of FMF and SLE have been published in the literature. [4] [5] [6] [7] [8] There are two speculations that FMF may protect against SLE. Ozen et al. 9 suggested that high levels of CRP in FMF patients play an important role in the removal of apoptotic materials, and this may protect FMF patients from developing SLE. The other hypothesis attributes the protective association between SLE and FMF to the absence of anti-serum amyloid P (SAP) antibodies. SAPs have a role in the clearance of nuclear ligands of apoptotic and necrotic cells and are absent in FMF patients. 4 Some drugs (procainamide, hydralazine, quinine, etc.) may induce symptoms overlapping with those of SLE. 10 However, our patient had no drug usage. Moreover, she had renal involvement, which is more suggestive for idiopathic SLE.
In conclusion, although coexistence is very rare, a patient with SLE who has abdominal pain and arthralgia episodes and/or does not respond to appropriate treatment should be evaluated for FMF.
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